
Ethereum News: 180 Life Sciences’ Desperate $425M ETH Gamble After 99.9% Stock Crash
In a shocking twist, Nasdaq-listed 180 Life Sciences has announced a $425 million Ethereum (ETH) investment after its stock value plummeted 99.9% since its 2020 IPO. This desperate pivot from biotech to crypto raises critical questions about corporate survival strategies in volatile markets. Why is 180 Life Sciences betting on Ethereum? The struggling biotech firm […]